TM & Partners advised NextCell on the deal.NextCell Pharma AB (publ) secured its rights issue of units, consisting of shares and warrants, of approximately SEK 40…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
